Consolidated Statement Of Income

TORII PHARMACEUTICAL CO., LTD. - Filing #7314142

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Consolidated statement of income
Statement of income
Net sales
28,309,000,000 JPY
25,699,000,000 JPY
Operating expenses
Selling, general and administrative expenses
9,466,000,000 JPY
10,418,000,000 JPY
Other
4,938,000,000 JPY
4,612,000,000 JPY
Cost of sales
15,701,000,000 JPY
13,770,000,000 JPY
Operating expenses
Operating profit (loss)
3,141,000,000 JPY
1,510,000,000 JPY
Gross profit (loss)
12,607,000,000 JPY
11,928,000,000 JPY
Ordinary profit (loss)
2,985,000,000 JPY
1,543,000,000 JPY
Operating expenses
Research and development expenses
1,363,000,000 JPY
2,413,000,000 JPY
Net sales
Non-operating income
223,000,000 JPY
202,000,000 JPY
Dividend income
53,000,000 JPY
56,000,000 JPY
Interest income
157,000,000 JPY
134,000,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating income
Other
12,000,000 JPY
11,000,000 JPY
Extraordinary losses
8,000,000 JPY
2,000,000 JPY
Non-operating expenses
379,000,000 JPY
170,000,000 JPY
Interest expenses
0 JPY
0 JPY
Non-operating expenses
Other
9,000,000 JPY
0 JPY
Profit (loss) before income taxes
2,976,000,000 JPY
1,540,000,000 JPY
Gross profit
Extraordinary losses
Loss on retirement of non-current assets
8,000,000 JPY
2,000,000 JPY
Income taxes
755,000,000 JPY
453,000,000 JPY
Profit (loss)
2,221,000,000 JPY
1,086,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.